Author: raincastle

Alzheimer’s Association International Conference (AAIC) 2025

Spear Bio at the 2025 Alzheimer’s Association International Conference (AAIC): Advancing Alzheimer’s Disease Biomarker Research Spear Bio is proud to sponsor the 2025 Alzheimer’s Association International Conference (AAIC) in Toronto, Canada, July 27–30. Join us as we unveil our new SPEAR UltraDetect™ Assay portfolio—designed to accelerate discovery and advance Alzheimer’s disease research. Revolutionizing Biomarker Research […]

Read More

Spear Bio Secures FDA Breakthrough Device Designation for its novel pTau 217 Blood Test, Advancing Scalable Solutions for Early Alzheimer’s Disease Diagnosis

Woburn, MA – January 13, 2025 – Spear Bio Inc., a biotechnology company pioneering next-generation ultra-sensitive immunoassays, today announced that its pTau 217 blood test has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This recognizes the test’s potential to address a critical unmet need for the millions of Americans […]

Read More

AD/PD™ Alzheimer’s & Parkinson’s Diseases Conference 2025

Spear Bio at the 2025 AD/PD™ Conference: Advancing Alzheimer’s & Parkinson’s Disease Research Spear Bio is excited to sponsor the 2025 AD/PD™ Alzheimer’s & Parkinson’s Diseases Conference in Vienna, Austria, from April 1-5. In addition, we’re showcasing our latest innovations to help researchers make breakthroughs in these challenging diseases. Revolutionizing Biomarker Research with SPEAR Technology […]

Read More

Spear Bio, Developer of the Next-generation Ultrasensitive Immunodiagnostics and Proteomics Platform, Completes Raise of Tens of Millions of US Dollars With Oversubscribed Seed Prime

WOBURN, Mass., Nov. 29, 2023 /PRNewswire/ — Spear Bio Inc., a Harvard University biotech spin-off developing scalable solutions for ultrasensitive detection of protein biomarkers announced the completion of a raise of tens of millions of US dollars with its Seed Prime.

Read More

Spear Bio Receives ISO 13485:2016 Certification

WOBURN, MA. Aug. 17, 2023– Ultrasensitive immunoassays developer Spear Bio has announced that it has received ISO certification for operating a “Quality Management System which complies with the requirements of ISO 13485: 2016.”

Read More

New Spear Bio Ultrasensitive Immunoassay Neutralizing Antibodies Test Kits for Covid Variants

Woburn, MA, July 10, 2023 – Ultrasensitive immunoassays developer Spear Bio is expanding its family of NAB-Sure SARS Cov-2 Neutralizing Antibodies test kits. Previously released kits included the original Wild Type strain and Omicron BA.4/5 variants. It has now added test kits for Omicron variants XBB.1.5 and BQ.1.1.

Read More

Spear Bio Co-Founder Feng Xuan to Present at Vaccines Summit this Month in Boston

WOBURN, Mass., May 15, 2023 /PRNewswire/ — Spear Bio co-founder, President & CTO, Feng Xuan, Ph.D. will be presenting at the upcoming Vaccines Summit (#VSBoston, May 22-24) at the Boston Marriott Newton Hotel. This summit brings together leading biotech and pharma industry experts, academics, and decision-makers for the latest vaccine R&D updates, global perspectives, collaboration, and networking.

Read More

Spear Bio expands NAB-Sure™ Assays to Support Study of SARS-CoV-2 Variants

NAB-Sure ™, the new cell-free SARS-CoV-2 neutralizing antibody assay will be featured at Vaccine Summit in Washington D.C. PRESS RELEASE Woburn, MA, October 11 2022 – Feng Xuan, Spear Bio’s Co-Founder and chief technology officer, will share insightful research and results featuring NAB-Sure™ – a new, ultrasensitive immunoassay – during the Vaccine Summit 2022.

Read More

Spear Bio Co-founder and CTO to present at Vaccine Summit

Spear Bio is expanding its NAB-Sure™ Neutralizing Antibody Test Kit product line with current SARS-CoV-2 variants. This addresses the need of researchers and vaccine developers faced with emerging SARS-CoV-2 variants as they continue to study immune responses to COVID-19 and protection durability of vaccines.

Read More

Immunoassay Technology Developer Spear Bio Presents Its NAB-Sure™ SARS-CoV-2 Neutralizing Antibody Test Kit at the American Association of Clinical Chemistry’s Annual Event

Woburn, MA, August 31, 2022 – Developer of ultrasensitive protein detection platform, Spear Bio (www.spear.bio), presented its breakthrough immunoassay technology at the recent American Association of Clinical Chemistry’s scientific meeting and clinical lab expo, held in Chicago.

Read More